Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

European Journal of Immunology

Volumn 30, Issue 10, 2000, Pages 2815-2823

  Yoshioka, Taro ^a   Nakajima, Atsuo ^a,b,d   Akiba, Hisaya ^b,c   Ishiwata, Toshiyuki ^a   Asano, Goro ^a   Yoshino, Shin Ichi ^a   Yagita, Hideo ^b,c   Okumura, Ko ^b,c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d NONE   (United States)

Author keywords

Co stimulation; Collagen induced arthritis; OX40 OX40L; Rheumatoid arthritis; Th1

Indexed keywords

COLLAGEN TYPE 2; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; LIGAND; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN OX40; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

EID: 0033785481     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200010)30:10<2815::aid-immu2815>3.0.co;2-%23     Document Type: Article

References (57)

1. T cell-dependent pathways in rheumatoid arthritis
2. Transfer of rheumatoid arthritis into severe combined immunodeficient mice
3. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: Suppression of arthritis without reduction of anti-type II collagen autoantibody levels
4. Therapeutic effects of monoclonal antibodies to αβTCR but not to CD4 on collagen-induced arthritis in the rat
5. Depletion of alpha/beta T cells by a monoclonal antibody against the αβ T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats
6. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4
7. The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities
8. Th1/Th2 cytokine balance in arthritis
9. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis
10. Relationship beween Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis
11. Suppression of collagen-induced arthritis by continuous administration of IL-4
12. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
13. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
14. CD28/B7 system of T cell costimulation
15. Differential T cell costimulatory requirements in CD28-deficient mice
16. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and cell death
17. + T cell response
18. Fas and FasL in the homeostatic regulation of immune responses
19. - T lymphocytes by 4-1BB ligand
20. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
21. Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34
22. Cloning of mouse OX40: A T cell activation marker that may mediate T-B cell interaction
23. Ox40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses
24. Expression and function of OX40 ligand on human dendritic cells
25. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells
26. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
27. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response
28. CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1
29. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells
30. Role of cytokines in rheumatoid arthritis
31. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis
32. Serum transfer of collagen-induced arthritis in mice
33. Induction of arthritis with monoclonal antibodies to collagen
34. Cytokines induce the development of functionally heterogeneous T helper cell subsets
35. The expanding universe of T cell subsets: Th1, Th2 and more
36. Lymphokine control of in vivo immunoglobulin isotype selection
37. OX40 is differentially expressed on activated rat and mouse T ceils and is the sole receptor for the OX40 ligand
38. Selective depletion of myelin-reactive T cells with the anti-OX40 antibody ameliorates autoimmune encephalomyelitis
39. Blocking OX40/OX40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis
40. Regulation of T cell adhesion in vitro and in vivo by targetting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-lg fusion protein, but not with an OX40 ligand-lg fusion protein
41. + T lymphocytes in chronic synovitis
42. Immune function in severe, active rheumatoid arthritis: A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles
43. HLA-DR positive T lymphocytes in blood and synovial fluid in rheumatoid arthritis
44. CD28-deficient mice are highly resistant to collagen-induced arthritis
45. Collagen-induced arthritis in BB rat. Prevention of disease by treatment with CTLA4-1g
46. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
47. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice
48. Manipulation of the Th1/Th2 balance in autoimmune disease
49. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Appplication to autoimmune disease therapy
50. CD28-B7 costimulatory blockade by CTLA4lg prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spare Th2 cytokines in the central nervous system
51. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
52. OX40-ligand has a critical costimulatory role in dendritic cell: T cell interactions
53. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection
54. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand
55. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule
56. + T lymphocytes into inflamed joint of rheumatoid arthritis
57. Expression of Fas ligand and its receptor in cutaneous lupus: Implication in tissue injury